IRIDEX Corporation — Q2 2016 Form 10-Q
Reporting period: Quarter and six months ended July 2, 2016; comparative periods ended July 4, 2015. IRIDEX develops, manufactures and sells ophthalmic laser systems, delivery devices, consumables, and related services. Amounts below are in millions of dollars unless stated otherwise.
Financial performance and liquidity
| Metric | Q2 2016 | Q2 2015 | Six months 2016 | Six months 2015 |
|---|---|---|---|---|
| Revenue | $11.91 | $9.03 | $23.84 | $19.83 |
| Gross profit / margin | $5.73 / 48.2% | $4.22 / 46.7% | $11.03 / 46.3% | $9.63 / 48.6% |
| Operating loss | $(0.39) | $(0.75) | $(0.24) | $(0.34) |
| Net loss | $(0.33) | $(0.65) | $(0.23) | $(0.41) |
| Net loss per share, diluted | $(0.03) | $(0.07) | $(0.02) | $(0.04) |
- Six-month operating cash flow was $1.83 million, versus $0.39 million in the prior-year period. Investing used $0.56 million and financing provided $0.26 million. Cash increased $1.53 million to $11.52 million.
- At July 2, cash was $11.52 million, working capital was $24.0 million, and total current assets and liabilities were $32.67 million and $8.66 million, respectively. Total liabilities were $9.23 million. The company reported no fixed- or variable-rate debt outstanding.
- Six-month capital expenditures were $0.37 million; earn-out payments were $0.19 million. Operating leases and purchase commitments totaled $12.87 million, including $6.21 million due within one year.
Material changes and management commentary
- Q2 revenue rose 31.8%; six-month revenue increased 20.2%. Management attributed the growth mainly to Cyclo G6 platform sales and noted that prior-year sales were affected by supply-chain issues that constrained system shipments.
- Q2 domestic and international system revenue increased 37.5% and 39.2%, respectively; recurring revenue increased 26.0%. For the first half, system revenue growth was 22.2% domestically and 33.5% internationally, while recurring revenue rose 12.0%.
- Q2 gross margin improved 1.5 percentage points, primarily from a mix shift toward higher-margin disposable probes. First-half gross margin declined 2.3 points, primarily due to a mix shift toward lower-margin system sales.
- General and administrative expense rose 76.1% in Q2 and 23.8% for the first half, primarily due to termination and severance costs, bonuses and stock compensation. Q2 included a $0.22 million charge related to accelerated vesting following an employee termination.
Outlook, risks and unusual items
- No specific revenue or earnings guidance was provided. Management stated that existing cash and expected operating cash flows should provide sufficient liquidity for the next 12 months; actual results may vary.
- Management cautioned that gross margins may fluctuate with product and geographic mix, new products, manufacturing variances, and production efficiency. The filing also identifies recent production difficulties and quality issues that led to reduced shipments, particularly to international distributors.
- Key risks include reliance on international distributors and sole- or limited-source suppliers, manufacturing and product-quality challenges, competition, regulatory and reimbursement changes, and foreign-exchange effects on product competitiveness. International sales and costs were denominated in U.S. dollars during the reported period; the company did not hedge currency exposure.
- The company reported an $0.85 million contingent earn-out liability, measured using significant unobservable assumptions. Ordinary-course legal matters were not expected to have a material adverse effect. The stock-repurchase authorization, with about $1.0 million remaining, was scheduled to expire August 15, 2016.
- Management reported effective disclosure controls and no material changes in internal control over financial reporting during the period.
Important facts for investors to verify
- Whether Cyclo G6 sales growth and recurring-revenue trends continue, and how much growth reflects recovery from prior-year supply constraints.
- Whether manufacturing and quality issues are resolved without further shipment delays, cost increases or customer impact.
- Whether revenue and product mix support gross-margin improvement, especially given the first-half margin decline.
- Whether operating cash generation is sustainable after working-capital movements, and how the $12.87 million of commitments and earn-out obligations affect liquidity.
- How severance, bonuses and stock-based compensation affect future operating expenses; the filing does not provide quantitative forward guidance.